Mar 4, 2026 09:25AM
Mar 4, 2026 09:25AM
Feb 5, 2026 09:15AM
Jan 22, 2026 09:22AM
Jan 22, 2026 09:20AM
Jan 12, 2026 09:10AM
Jan 12, 2026 09:10AM Lexaria Releases Annual Letter from the CEO
Dec 30, 2025 09:20AM
Dec 30, 2025 09:20AM
Dec 29, 2025 05:13PM
Dec 26, 2025 06:42AM
Dec 23, 2025 09:29AM
Dec 23, 2025 09:29AM
Dec 16, 2025 04:00PM Lexaria Bioscience closes $3.5 million registered direct offering
Dec 16, 2025 04:00PM
Dec 15, 2025 08:01AM
Dec 15, 2025 08:00AM
Dec 5, 2025 04:03PM
Nov 12, 2025 09:11AM
Nov 12, 2025 09:10AM
Oct 9, 2025 09:20AM Lexaria Bioscience hires advisory firm, receives 4 new patents
Oct 9, 2025 09:20AM
Sep 29, 2025 04:30PM
Sep 29, 2025 04:30PM
Sep 26, 2025 08:00AM
Sep 26, 2025 08:00AM
Sep 19, 2025 11:25AM
Sep 19, 2025 11:20AM Lexaria's Technology Supports Higher Levels of the GLP-1 Drug Semaglutide in Brain
Aug 27, 2025 09:20AM
Aug 14, 2025 09:20AM
Aug 14, 2025 09:20AM
Aug 6, 2025 09:20AM
Jul 29, 2025 06:41AM
Jul 28, 2025 09:25AM
Jul 28, 2025 09:25AM Lexaria Provides Positive Interim Results on Partial 8-week Data from Phase 1b, GLP-1-H24-4 Study
Jul 23, 2025 09:28AM
Jul 23, 2025 09:25AM
Jul 1, 2025 06:42AM
Jun 23, 2025 09:15AM
Jun 23, 2025 09:15AM
Jun 13, 2025 04:10PM
Jun 11, 2025 09:05AM Lexaria's (LEXX) DehydraTECH-Liraglutide Human GLP-1 Clinical Study Supports Pathway to Potential FDA Registration as an Orally-Delivered Capsule
Jun 11, 2025 09:05AM
Jun 5, 2025 09:20AM
May 12, 2025 09:02AM
May 12, 2025 09:00AM
Apr 28, 2025 04:15PM
Apr 25, 2025 08:02AM
Apr 25, 2025 08:00AM Lexaria Announces $2 Million Registered Direct Offering of Common Stock
Apr 23, 2025 09:10AM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All